You searched for "glaucoma care"
Cutting-edge practice in glaucoma care: what, how and why?
More effective treatments and drug delivery modalities, implantable minimally invasive glaucoma surgical (MIGS) devices, as well as accelerating clinical research programmes, will transform the surgical and clinical management of glaucoma in the near future. There is also an ever-greater emphasis...Sharing best practice and landmark evidence in glaucoma care
Evolving technology, best practice and landmark evidence in glaucoma care were reviewed by an international expert faculty in session presentations and debates during the 11th Moorfields International Glaucoma Symposium 2019. The authors were meeting chairs and provide an overview of...
Screening and adherence to glaucoma care in Enugu, Nigeria
The authors present the findings of a cross-sectional survey of participants diagnosed with glaucoma during free eye screening. A total of 830 participants were screened from two outreaches:182 new glaucoma cases were diagnosed (63 glaucoma and 119 glaucoma suspects). There...Glaucoma care provision using a multidisciplinary approach: a personal view
This article is going to explain the secret to running an efficient multidisciplinary glaucoma service which will comfortably meet the demands of an ever-growing elderly population, within the confines of budgetary and clinical constraints, wherever the setting. This may be...Glaucoma UK ‘Excellence in Glaucoma Care Award 2024’ Winner Announcement
PhD student at Glasgow Caledonian University wins the Glaucoma UK ‘Excellence in Glaucoma Care Award 2024’.Winner Announcement - Glaucoma UK ‘Excellence in Glaucoma Care Award 2023’
Dr Sancy Low, Consultant Ophthalmic Surgeon at Guy’s and St Thomas’ NHS Foundation Trust, wins the Glaucoma UK ‘Excellence in Glaucoma Care Award 2023’.Researchers pursue personalised pathways for glaucoma care
Researchers, funded by Glaucoma UK in partnership with The Royal College of Ophthalmologists, are investigating the potential for personalised glaucoma care by mapping clinical trial data and real-word outcomes to individuals.BELKIN Vision is pleased to announce FDA clearance for its glaucoma laser, the Eagle device
BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.
Risk factors and untreated POAG
The authors examined 50 untreated open angle glaucoma patients to determine if there was an association between the level of glaucomatous damage and documented risk factors. In this study the authors measured the extent of morphologic and functional glaucomatous damage...
